These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11565217)

  • 1. [Invasive meningococcal infections in the Fribourg canton. Reasons for and development of a vaccination program in Gruyere in February 2001].
    Renevey F; Demierre G; Chuard C; Regamey C
    Rev Med Suisse Romande; 2001 Aug; 121(8):569-72. PubMed ID: 11565217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccine coverage survey per cluster sampling after an antimeningococcal mass vaccination campaign at Niamey, Niger in 2000].
    de Chabalier F; Garba A; Chippaux JP
    Sante; 2001; 11(3):173-6. PubMed ID: 11641081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance of invasive meningococcal disease in the Czech Republic.
    Kriz P
    Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal disease in Newfoundland, 1967-1991.
    Can Commun Dis Rep; 1992 Aug; 18(15):116-7. PubMed ID: 1290995
    [No Abstract]   [Full Text] [Related]  

  • 7. Meningococcal disease: was Ottawa's mass-vaccination program necessary?
    Gray C
    CMAJ; 1992 Mar; 146(6):1033, 1036-7. PubMed ID: 1544060
    [No Abstract]   [Full Text] [Related]  

  • 8. Meningococcal B immunisation in New Zealand: why haven't we seen the data?
    Bolland M
    N Z Med J; 2008 Mar; 121(1270):107-9. PubMed ID: 18364764
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 10. EpiReview: Meningococcal disease in NSW, 1991-2011: trends in relation to meningococcal C vaccination.
    Passmore E; Ferson MJ; Tobin S
    N S W Public Health Bull; 2013 Dec; 24(3):119-24. PubMed ID: 24360208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal infections in Quebec--1991-92.
    Lavigne P; Boulianne N; Fortin C; Naccache H; Douville-Fradet M
    Can Commun Dis Rep; 1992 Aug; 18(15):113-6. PubMed ID: 1290994
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control.
    Can Fam Physician; 1994 Dec; 40():2121-3. PubMed ID: 7888825
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meningococcal diseases in Austria].
    Thiel W; Haas G; Heuberger S
    Wien Klin Wochenschr; 1998 Jun; 110(12):415-22. PubMed ID: 9677660
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal disease in Ironville.
    Commun Dis Rep CDR Wkly; 1999 Aug; 9(34):297. PubMed ID: 10502876
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 18. Seasonal rise in meningococcal disease: chief medical officer writes to all doctors.
    Commun Dis Rep CDR Wkly; 1999 Jan; 9(4):29, 32. PubMed ID: 9988960
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001.
    Squires SG; Deeks SL; Tsang RS
    Can Commun Dis Rep; 2004 Feb; 30(3):17-28. PubMed ID: 14971276
    [No Abstract]   [Full Text] [Related]  

  • 20. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.